PortfoliosLab logo
Silver Spike Investment Corp (SSIC)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US8281741020

IPO Date

Feb 4, 2022

Highlights

Market Cap

$66.72M

EPS (TTM)

$0.90

PE Ratio

11.93

Total Revenue (TTM)

$2.32M

Year Range

$10.54 - $13.38

Target Price

$8.80

Short %

0.58%

Short Ratio

4.63

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Silver Spike Investment Corp

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period


SSIC

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

0.51%

1M

6.15%

6M

-2.00%

1Y

12.92%

3Y*

12.68%

5Y*

14.19%

10Y*

10.85%

*Annualized

Monthly Returns

The table below presents the monthly returns of SSIC, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-8.89%31.86%-2.76%17.59%0.44%6.43%1.41%-4.40%-5.14%20.82%-0.43%0.23%62.88%
20231.84%-0.50%-7.45%-10.23%1.70%-2.55%0.55%19.45%5.13%-3.10%1.07%-4.13%-1.09%
2022-0.00%-5.00%-20.50%-4.96%-2.69%1.23%-1.52%2.56%4.50%-0.12%-6.10%-30.00%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

With an overall rank of 92, SSIC is among the top 8% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of SSIC is 9292
Overall Rank
The Sharpe Ratio Rank of SSIC is 9494
Sharpe Ratio Rank
The Sortino Ratio Rank of SSIC is 9393
Sortino Ratio Rank
The Omega Ratio Rank of SSIC is 9292
Omega Ratio Rank
The Calmar Ratio Rank of SSIC is 8787
Calmar Ratio Rank
The Martin Ratio Rank of SSIC is 9393
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Silver Spike Investment Corp (SSIC) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Silver Spike Investment Corp. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History

Silver Spike Investment Corp provided a 3.90% dividend yield over the last twelve months, with an annual payout of $0.50 per share.


8.06%$0.00$0.10$0.20$0.30$0.40$0.50$0.60$0.702023
Dividends
Dividend Yield
PeriodTTM2023
Dividend$0.50$0.68

Dividend yield

3.90%8.06%

Monthly Dividends

The table displays the monthly dividend distributions for Silver Spike Investment Corp. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.25$0.00$0.00$0.00$0.75
2023$0.23$0.00$0.00$0.45$0.68

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Silver Spike Investment Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Silver Spike Investment Corp was 46.91%, occurring on Jul 25, 2023. Recovery took 227 trading sessions.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-46.91%Mar 14, 2022343Jul 25, 2023227Jun 18, 2024570
-10.25%Jun 20, 202471Sep 30, 20244Oct 4, 202475
-4.76%Oct 16, 202422Nov 14, 2024
-4.64%Feb 14, 202215Mar 7, 20224Mar 11, 202219
-0.7%Oct 11, 20241Oct 11, 20241Oct 14, 20242
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Silver Spike Investment Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Silver Spike Investment Corp, comparing actual results with analytics estimates. The company has exceeded analyst expectations for EPS in the past quarter, achieving a 312.5% positive surprise.


-0.60-0.40-0.200.000.200.402022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025
0.21
0.08
Actual
Estimate

Valuation

The Valuation section provides an overview of how Silver Spike Investment Corp is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for SSIC, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, SSIC has a P/E ratio of 11.9. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SSIC relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, SSIC has a P/S ratio of 5.4. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for SSIC in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, SSIC has a P/B value of 3.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items